Table 1. Comparisons of sociodemographic characteristics of subjects who were prescribed Zolpidem and comparison subjects, 2005–2007 (n = 154,072).
| Variable | Subjects who were prescribed Zolpidem (n = 77,036) | Comparison subjects (n = 77,036) | P value | ||
| Total No. | % | Total No. | % | ||
| Sex | 1.000 | ||||
| Male | 29,810 | 38.7 | 29,810 | 38.7 | |
| Female | 47,226 | 61.3 | 47,226 | 61.3 | |
| Age (years) | 1.000 | ||||
| 18–29 | 8,039 | 10.4 | 8,039 | 10.4 | |
| 30–39 | 11,300 | 14.7 | 11,300 | 14.7 | |
| 40–49 | 15,410 | 20.0 | 15,410 | 20.0 | |
| 50–59 | 16,039 | 20.8 | 16,039 | 20.8 | |
| 60–69 | 11,399 | 14.8 | 11,399 | 14.8 | |
| 70–79 | 10,229 | 13.3 | 10,229 | 13.3 | |
| >79 | 4,620 | 6.0 | 4,620 | 6.0 | |
| Monthly income | 0.271 | ||||
| ≤ NT15,840 | 34,894 | 45.3 | 34,655 | 45.0 | |
| NT$15,841-25,000 | 26,803 | 34.8 | 26,807 | 34.8 | |
| ≥ NT$25,001 | 15,339 | 19.9 | 15,574 | 20.2 | |
| Urbanization level | 1.000 | ||||
| 1 (most urbanized) | 22,382 | 29.1 | 22,382 | 29.1 | |
| 2 | 21,984 | 28.5 | 21,984 | 28.5 | |
| 3 | 11,911 | 15.5 | 11,911 | 15.5 | |
| 4 | 11,218 | 14.5 | 11,218 | 14.5 | |
| 5 (least urbanized) | 9,541 | 12.4 | 9,541 | 12.4 | |
| Geographic region | 0.256 | ||||
| Northern | 35,963 | 46.7 | 35,618 | 46.2 | |
| Central | 20,262 | 26.3 | 20,600 | 26.7 | |
| Southern | 18,375 | 23.8 | 18,262 | 23.7 | |
| Eastern | 2,436 | 3.2 | 2,556 | 3.4 | |
| Cardiac arrhythmias | 9,911 | 12.9 | 4,745 | 6.2 | <0.001 |
| Congestive heart failure | 6,314 | 8.2 | 3,110 | 4.0 | <0.001 |
| Valvular disease | 1,926 | 2.5 | 847 | 1.1 | <0.001 |
| Pulmonary circulation disorders | 157 | 0.2 | 71 | 0.1 | <0.001 |
| Periphreal vascular disorders | 4,202 | 5.5 | 2,175 | 2.8 | <0.001 |
| Hypertension | 33,683 | 43.7 | 22,924 | 29.8 | <0.001 |
| Paralysis | 2,422 | 3.1 | 1,454 | 1.9 | <0.001 |
| Coagulopathy | 816 | 1.1 | 461 | 0.6 | <0.001 |
| Other neurological disorders | 4,622 | 6.0 | 1,878 | 2.4 | <0.001 |
| Chronic pulmonary disease | 19,298 | 25.1 | 11,763 | 15.3 | <0.001 |
| Diabetes, uncomplicated | 15,222 | 19.8 | 9,996 | 13.0 | <0.001 |
| Diabetes, complicated | 7,099 | 9.2 | 4,099 | 5.3 | <0.001 |
| Hypothyroidism | 8,119 | 10.5 | 4,764 | 6.2 | <0.001 |
| Renal failure | 3,251 | 4.2 | 1,581 | 2.1 | <0.001 |
| Liver disease | 18,317 | 23.8 | 11,314 | 14.7 | <0.001 |
| Peptic ulcer disease excluding bleeding | 23,331 | 30.3 | 13,010 | 16.9 | <0.001 |
| Solid tumor without metastatsis | 6,118 | 7.9 | 3,155 | 4.1 | <0.001 |
| Rheumatoid arthritis | 6,944 | 9.0 | 3,885 | 5.0 | <0.001 |
| Fluid and electrolyte disorders | 3,453 | 4.5 | 1,288 | 1.7 | <0.001 |
| Blood loss anemia | 497 | 0.7 | 314 | 0.4 | <0.001 |
| Deficiency anemias | 2,157 | 2.8 | 1,156 | 1.5 | <0.001 |
| Alcohol abuse | 1,435 | 1.9 | 219 | 0.3 | <0.001 |
| Drug abuse | 3,316 | 4.3 | 1,174 | 1.5 | <0.001 |
| Psychoses | 11,548 | 15.0 | 1,452 | 1.9 | <0.001 |
| Depression | 16,676 | 21.7 | 2,130 | 2.8 | <0.001 |
| AIDS | 60 | 0.0 | 52 | 0.0 | 0.449 |
| Lymphoma | 1,695 | 2.2 | 847 | 1.1 | <0.001 |
| Metastatic cancer | 554 | 0.7 | 165 | 0.2 | <0.001 |
| Obesity | 966 | 1.3 | 554 | 0.7 | <0.001 |
| Weight loss | 462 | 0.6 | 257 | 0.3 | <0.001 |